Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WFEMF ~ Very promising stock like FNMA or FMCC
Read more about WFEMF at:
http://investorshub.advfn.com/Woulfe-Mining-Corp-WFEMF-23053/
Gold mines are a dime a dozen but a world class tungsten mine is unique and could prove to be extremely valuable. In my opinion tungsten is a good bet to make just in case gold or other metal prices collapse in the future.
WFEMF ~ If played right, Woulfe Mining could become a MAJOR over the next decade and beyond, but they've got to get this Sangdong Mine running first! Advice (if you are willing to take it): 'Be like Warren Buffett & Ned Goodman', build a large position, then sit for a long time...
Cheers!
Read more about WFEMF at:
http://ih.advfn.com/p.php?pid=squote&symbol=WFEMF
WFEMF ~ If played right, Woulfe Mining could become a MAJOR over the next decade and beyond, but they've got to get this Sangdong Mine running first! Advice (if you are willing to take it): 'Be like Warren Buffett & Ned Goodman', build a large position, then sit for a long time...
Cheers!
Read more about WFEMF at:
http://ih.advfn.com/p.php?pid=squote&symbol=WFEMF
Why is the TUCND stock price collapsing?
Check out WFEMF on investors hub. This stock could help you make back your losses and then some but it's more of a long term investment.
Cohen, Placitella & Roth, PC Investigating Forest Oil, Inc. for Misleading Statements Regarding Results and Debt Agreements
http://ih.advfn.com/p.php?pid=nmona&article=61256952
Retail Guru Brian Sozzi Remains A JC Penney Skeptic Following Q4 Results
Brian Sozzi, chief equities strategist at Belus Capital Advisors, released a note following J.C. Penney's (NYSE: JCP) bullish fourth quarter earnings report. Sozzi compared the report to “the smile of a cute puppy” that lures you from afar. Sozzi goes on to warn the same puppy “could pee on you if not careful to move out of the way.”
Women and children's apparel was not a top-performing area, which raises concerns about J.C. Penney's ability to “earn profits in must-shop periods such as back to school and the holidays,” Sozzi said.
“FY14 guidance has outlined a mid-single digit positive comp,” but “in order to survive, J.C. Penney must be now transitioning to double digit percentage positive comps off year earlier AND renewed promotional activity in the store,” warned the Belus analyst.
Sozzi reiterated a Selling rating on shares of J.C. Penney following the quarterly figures.
Investors do indeed seem to be hypnotized by the puppy's smile; in Wednesday's post-market session, the stock is trading up more than 13 percent to around $6.75.
Why does the GRPS stock price keep dropping?
I sense that this is going to get really ugly after JCP
releases their recent financial results.
J. C. Penney Company, Inc. to Report Fourth Quarter 2013 Financial Results on February 26, 2014 at 4:00 p.m. ET
The JCP shareholders will be wiped out if the company files for bankruptcy protection. I highly doubt those fat cats in the JCP upper management will voluntarily give up their fancy private jets and outrageous compensation.
Buyers Beware! HPNN - Appears to be a Dilution Scheme/Scam.
Woulfe Sangdong mine site
Woulfe Sangdong mine site
Video: Why Warren Buffett Likes Tungsten
http://www.theglobeandmail.com/report-on-business/video-why-warren-buffett-likes-tungsten/article4171802/
International Metalworking Companies, which is now 100%-owned by Warren Buffett's Berkshire Hathaway, is currently in negotiations with Woulfe Mining to finalize a joint venture and offtake deal to help bring the Sangdong tungsten-molybdenum mine into production.
Video: Why Warren Buffett Likes Tungsten
http://www.theglobeandmail.com/report-on-business/video-why-warren-buffett-likes-tungsten/article4171802/
International Metalworking Companies, which is now 100%-owned by Warren Buffett's Berkshire Hathaway, is currently in negotiations with Woulfe Mining to finalize a joint venture and offtake deal to help bring the Sangdong tungsten-molybdenum mine into production.
CHTP - Today's News, February 18, 2014
4:54p
Chelsea Therapeutics: Northera Is First and Only Therapy Approved by FDA Which Demonstrates Symptomatic Benefit in NOH Patients (Dow Jones)
4:53p
Chelsea Therapeutics Announces FDA Accelerated Approval of NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic NOH (Business Wire)
4:53p
Chelsea Therapeutics Announces FDA Accelerated Approval Of NORTHERA(TM) (Droxidopa) For The Treatment Of Symptomatic NOH >CHTP (Dow Jones)
4:53p
Chelsea Therapeutics : FDA Gave Accelerated Approval to Northera for Treatment of Symptomatic NOH >CHTP (Dow Jones)
4:35p
FDA OKs Chelsea Therapeutics' Northera to Treat Neurogenic Orthostatic Hypotension >CHTP (Dow Jones)
There is two catalysts that will move the CHTP stock price up. It might be best to hold for buyout news. The CEO claimed in an interview that he is interested in selling the company.
Today's News, February 18, 2014
1:04p
Chelsea Therapeutics Moves Higher on Heavy Volume (Benzinga)
Adam Feuerstein Chimes in on Odds of Approval
Adam Feuerstein, Wall Street's definitive biotech source, reported his prediction on the odds that the FDA will approve the experimental drug Northera. Feuerstein estimates that Northera has a 70 percent chance of passing on Friday. The source noted his concern on the "small chance FDA delays the Northera decision given the short amount of time between Friday's approval decision date and last month's positive advisory panel. A short delay for administrative reasons -- meaning no requirements for additional clinical data -- won't matter much and may actually benefit Chelsea since the orphan indication clock doesn't start ticking until approval."
Heavy buying volume CHTP today.
It's pointless to halt the stock come Tuesday unless the SEC shuts this down to do a full investigation.
The damage has already been done.
Exactly! Which is why the con-artists who were involved used the situation to capitalize on this fiasco. Shareholders will find out when the company received the FDA weather delay notice. I'm pretty sure the FDA will provide that information come Tuesday. This was a well coordinated scam and shareholders with the help of their lawyers will get to the bottom of it. Think about this for a minute folks. A lot of people on here have jobs or attend college. Do they call you up at 7pm at night and tell you that they will be closed for the day due to weather problems or do they announce it early in the AM before everyone shows up? The only time they call people up around 7pm at night is if they want to inform people the night before the cancellations.
Expecting a CRL on Tuesday
.
The FDA approved other drugs on Friday but chose to delay their decision on CHTP. More than likely the company will receive a CRL. It's pretty obvious that the FDA is struggling to make a final decision and is leaning towards a CRL.
The CHTP stock price will drop like a rock if they announce a CRL
That is not true! All of the FACTS have NOT been gathered yet. Shareholders will find out the exact time the FDA informed CHTP about this weather delay come Tuesday morning of next week.
“There's always another story. There's more than meets the eye.”
W.H. Auden
You're not going to receive many truthful answers on this message board but what took place Friday was a well coordinated scam. Several people on this message board refuse to take off their rose colored glasses for various reasons. Some of them still own shares of the stock. CHTP investors will get to the bottom of this fiasco come Tuesday of next week. Just be patient and wait for the facts to be gathered. A lot of the shareholders are convinced that the CEO And management were well aware of the FDA cancellation several hours before they informed the shareholders. If that is not the case then the FDA and their cronies were responsible for this fiasco. This has tarnished the company's reputation and a lot of institutional buyers will now avoid this stock which will prevent the stock price from breaking out in the short term. The risk versus reward makes it no longer worth investing in this company. Expect a small pop up on the stock price if they receive FDA approval. I think there is more going on here than meets the eye. The possibility that CHTP will receive a CRL is stronger than ever before.
In my opinion the CHTP stock price will drop regardless of what happens. A lot of institutional buyers will not touch this stock with a 10 foot pole after the fiasco that happened Friday. It could take a long time for the company's reputation to recover from what happened. They made the company appear like it's being ran by a bunch of Chinese scammers.
joro44
They didn't know this on Thursday night , Friday morning , Friday afternoon or Friday At 4.
Something smelling fishy.
The company could be running into some major problems or obstacles if there is no mention of the time limit for resubmission. This might drag on for weeks or even months while the company tries to get a handle on the situation.
Why was it denied to begin with? What is the major hold up here?
J.C. Penney Company, Inc. Is 1 Step Closer to Bankruptcy
By Adam Levine-Weinberg
February 6, 2014
JCP Liquidity problems ahead
J.C. Penney's ongoing poor performance puts the company on a path toward severe liquidity issues later this year, which could intensify further in 2015 -- if the company gets that far. J.C. Penney achieved its goal of ending the 2013 fiscal year with more than $2 billion of liquidity (cash and investments plus a credit line), but that shouldn't give investors much comfort.
The problem is that J.C. Penney burned $3 billion of cash through the first three quarters of its recently concluded fiscal year. In other words, at last year's rate, J.C. Penney would be out of cash by the fall.
http://www.fool.com/investing/general/2014/02/06/jc-penney-company-inc-is-1-step-closer-to-bankrupt.aspx
This small rally on JCP today seems to be premature. It's way too early to even begin to know if JCP can avoid bankruptcy.
Is This the End for J.C. Penney?
http://www.fool.com/investing/general/2014/01/23/is-this-the-end-for-jc-penney.aspx
How will JCP prevent the company from going bankrupt? How will management turn the company around?
A $4 price target on JCP seems reasonable but what happens if the company cannot turn things around by the end of 2014. JCP could see a price target of $2 or $3 per share by the end of 2014.
"Embattled retailer J.C. Penney (JCP) fell 60c, or 10.56%, to $5.08 despite reporting comparable store sales that grew 3.1% during the Holiday period. Deutsche Bank said it believes investors were expecting a positive low-single digit gain in same-store sales and it does not view today's press release as material to the J.C. Penney story, while Sterne Agee cut its price target on the retailer's shares to $3 from $9".
How much cash does the company have on hand? Will they need to raise more capital in the near future?
There might be some potential here but I still see this stock bleeding red for a while until the company can prove itself and successfully resubmit this new drug.
When do expect this to be up for FDA approval again? How long will this process take?
I'm a little confused about the recent news out on IGXT. I thought a CRL usually makes biotech stocks drop like a rock.